179 related articles for article (PubMed ID: 19340302)
1. HCV tumor promoting effect is dependent on host genetic background.
Klopstock N; Katzenellenbogen M; Pappo O; Sklair-Levy M; Olam D; Mizrahi L; Potikha T; Galun E; Goldenberg D
PLoS One; 2009; 4(4):e5025. PubMed ID: 19340302
[TBL] [Abstract][Full Text] [Related]
2. Interstrain differences in chronic hepatitis and tumor development in a murine model of inflammation-mediated hepatocarcinogenesis.
Potikha T; Stoyanov E; Pappo O; Frolov A; Mizrahi L; Olam D; Shnitzer-Perlman T; Weiss I; Barashi N; Peled A; Sass G; Tiegs G; Poirier F; Rabinovich GA; Galun E; Goldenberg D
Hepatology; 2013 Jul; 58(1):192-204. PubMed ID: 23423643
[TBL] [Abstract][Full Text] [Related]
3. Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
Potikha T; Pappo O; Mizrahi L; Olam D; Maller SM; Rabinovich GA; Galun E; Goldenberg DS
FASEB J; 2019 Jul; 33(7):7995-8007. PubMed ID: 30897344
[TBL] [Abstract][Full Text] [Related]
4. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
Gamaev L; Mizrahi L; Friehmann T; Rosenberg N; Pappo O; Olam D; Zeira E; Bahar Halpern K; Caruso S; Zucman-Rossi J; Axelrod JH; Galun E; Goldenberg DS
Oncogene; 2021 Jan; 40(1):127-139. PubMed ID: 33093654
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of aflatoxin B1-induced liver tumors in hepatitis virus C transgenic mice.
Jeannot E; Boorman GA; Kosyk O; Bradford BU; Shymoniak S; Tumurbaatar B; Weinman SA; Melnyk SB; Tryndyak V; Pogribny IP; Rusyn I
Int J Cancer; 2012 Mar; 130(6):1347-56. PubMed ID: 21500192
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis.
Moriya K; Nakagawa K; Santa T; Shintani Y; Fujie H; Miyoshi H; Tsutsumi T; Miyazawa T; Ishibashi K; Horie T; Imai K; Todoroki T; Kimura S; Koike K
Cancer Res; 2001 Jun; 61(11):4365-70. PubMed ID: 11389061
[TBL] [Abstract][Full Text] [Related]
8. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.
Lerat H; Honda M; Beard MR; Loesch K; Sun J; Yang Y; Okuda M; Gosert R; Xiao SY; Weinman SA; Lemon SM
Gastroenterology; 2002 Feb; 122(2):352-65. PubMed ID: 11832450
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice.
Barashi N; Weiss ID; Wald O; Wald H; Beider K; Abraham M; Klein S; Goldenberg D; Axelrod J; Pikarsky E; Abramovitch R; Zeira E; Galun E; Peled A
Hepatology; 2013 Sep; 58(3):1021-30. PubMed ID: 23526353
[TBL] [Abstract][Full Text] [Related]
10. Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice.
Kato T; Miyamoto M; Date T; Yasui K; Taya C; Yonekawa H; Ohue C; Yagi S; Seki E; Hirano T; Fujimoto J; Shirai T; Wakita T
Cancer Sci; 2003 Aug; 94(8):679-85. PubMed ID: 12901792
[TBL] [Abstract][Full Text] [Related]
11. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the Mdr2-knockout mice.
Katzenellenbogen M; Pappo O; Barash H; Klopstock N; Mizrahi L; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Mitchell LA; Kohen R; Domany E; Galun E; Goldenberg D
Cancer Res; 2006 Apr; 66(8):4001-10. PubMed ID: 16618719
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte IKK2 protects Mdr2-/- mice from chronic liver failure.
Ehlken H; Kondylis V; Heinrichsdorff J; Ochoa-Callejero L; Roskams T; Pasparakis M
PLoS One; 2011; 6(10):e25942. PubMed ID: 22022477
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice.
Herzer K; Carbow A; Sydor S; Sowa JP; Biesterfeld S; Hofmann TG; Galle PR; Gerken G; Canbay A
PLoS One; 2012; 7(9):e44474. PubMed ID: 22984515
[TBL] [Abstract][Full Text] [Related]
14. Promyelocytic leukemia protein deficiency leads to spontaneous formation of liver tumors in hepatitis C virus transgenic mice.
Straub K; Husen P; Baba HA; Trippler M; Wedemeyer H; Herzer K
Cancer Med; 2019 Jul; 8(8):3793-3802. PubMed ID: 31144474
[TBL] [Abstract][Full Text] [Related]
15. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein.
Furutani T; Hino K; Okuda M; Gondo T; Nishina S; Kitase A; Korenaga M; Xiao SY; Weinman SA; Lemon SM; Sakaida I; Okita K
Gastroenterology; 2006 Jun; 130(7):2087-98. PubMed ID: 16762631
[TBL] [Abstract][Full Text] [Related]
16. Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.
Stoyanov E; Ludwig G; Mizrahi L; Olam D; Schnitzer-Perlman T; Tasika E; Sass G; Tiegs G; Jiang Y; Nie T; Kohler J; Schinazi RF; Vertino PM; Cedar H; Galun E; Goldenberg D
Oncotarget; 2015 May; 6(13):11047-60. PubMed ID: 25918251
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Aoyama T
Int J Cancer; 2008 Jan; 122(1):124-31. PubMed ID: 17764115
[TBL] [Abstract][Full Text] [Related]
18. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.
Moriya K; Fujie H; Shintani Y; Yotsuyanagi H; Tsutsumi T; Ishibashi K; Matsuura Y; Kimura S; Miyamura T; Koike K
Nat Med; 1998 Sep; 4(9):1065-7. PubMed ID: 9734402
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo.
Bansal R; Frelin L; Brenndörfer ED; Storm G; Prakash J; Sällberg M
PLoS One; 2015; 10(6):e0128466. PubMed ID: 26030283
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Barash H; Domany E; Galun E; Goldenberg D
Mol Cancer Ther; 2007 Apr; 6(4):1283-91. PubMed ID: 17431106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
